(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MARTINDALE - THE COMPLETE DRUG REFERENCE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

MARTINDALE - THE COMPLETE DRUG REFERENCE

ST13

US500000078053361

Class

9, 16, 42

Filing

78053361

Registration

2917885

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

64

Latest update

05/27/2025

Trademark type

Word

Nice classes

9, 16, 42

Filing date

03/15/2001

Registration date

01/11/2005

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/04/2025

Last transaction

05/27/2025

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

First use anywhere

08/30/2004

First use in commerce

08/30/2004

Drawing code

1

Owner type

03

Owner location

LONDON, GB

Examiner

GARTNER, JOHN

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

R. B. (pessoa física)
R. B. (pessoa física)

Representatives

Shoko Naruo Thompson Coburn LLP

Technical classification

Nice Classes

Class 9Class 16Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 9

(Based on 44(e) and 44(d) Priority) Downloadable electronic publications in the nature of journalsmagazinesreference materialsall in the field of medicine and pharmacology; electronic database in the field of medicine and pharmacology recorded on computer media ; multimedia software recorded on CD-ROMs containing published material in the field of medicine and pharmacology

Class 16

(Based on 44(e) and 44(d) Priority) Series of non-fiction booksjournalsmagazinesinstruction materialsreference materialsall in the field of medicine and pharmacology

Class 42

(Based on Use in Commerce) Providing information regarding medicine and pharmacology via websites on the Internet; providing information on medicine and pharmacology for the purpose of updating existing databases via websites on the Internet

Publications

History of USPTO decisions and trademark events.

64 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

05/04/2025

RNL2

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

05/04/2025

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

05/04/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

04/04/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/18/2024

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

11/18/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

11/18/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

11/18/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

11/18/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

11/18/2024

E89R

TEAS SECTION 8 & 9 RECEIVED

11/18/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/14/2024

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

11/14/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

11/14/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

11/14/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

11/14/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

11/14/2024

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

01/11/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/04/2018

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/04/2018

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

06/01/2018

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

06/01/2018

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

01/27/2015

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

01/27/2015

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

01/27/2015

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

01/27/2015

E89R

TEAS SECTION 8 & 9 RECEIVED

01/10/2015

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

01/26/2011

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

01/26/2011

E815

TEAS SECTION 8 & 15 RECEIVED

01/07/2011

R.PR

REGISTERED-PRINCIPAL REGISTER

01/11/2005

REGV

LAW OFFICE REGISTRATION REVIEW COMPLETED

11/01/2004

ALIE

ASSIGNED TO LIE

10/29/2004

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

10/13/2004

DOCK

ASSIGNED TO EXAMINER

10/12/2004

SUPC

STATEMENT OF USE PROCESSING COMPLETE

09/21/2004

IUAF

USE AMENDMENT FILED

09/21/2004

EISU

TEAS STATEMENT OF USE RECEIVED

09/21/2004

FAXX

FAX RECEIVED

08/30/2004

PETG

PETITION TO REVIVE-GRANTED

07/07/2004

EX3G

SOU EXTENSION 3 GRANTED

04/25/2004

CFIT

CASE FILE IN TICRS

04/02/2004

PETR

PETITION TO REVIVE-RECEIVED

03/31/2004

MAIL

PAPER RECEIVED

03/31/2004

EEXT

SOU TEAS EXTENSION RECEIVED

03/26/2004

EXT3

SOU EXTENSION 3 FILED

03/25/2004

EXT2

SOU EXTENSION 2 FILED

03/25/2004

EX2G

SOU EXTENSION 2 GRANTED

03/07/2004

EX1G

SOU EXTENSION 1 GRANTED

10/02/2003

EXT1

SOU EXTENSION 1 FILED

09/24/2003

EEXT

SOU TEAS EXTENSION RECEIVED

09/24/2003

NOAM

NOA MAILED - SOU REQUIRED FROM APPLICANT

03/25/2003

PUBO

PUBLISHED FOR OPPOSITION

12/31/2002

NPUB

NOTICE OF PUBLICATION

12/11/2002

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/29/2002

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/21/2002

GNRT

NON-FINAL ACTION E-MAILED

09/25/2002

UNPR

UNRESPONSIVE/DUPLICATE PAPER RECEIVED

07/15/2002

MAIL

PAPER RECEIVED

07/15/2002

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/05/2002

MAIL

PAPER RECEIVED

07/05/2002

CNRT

NON-FINAL ACTION MAILED

01/04/2002

CNRT

NON-FINAL ACTION MAILED

07/06/2001

DOCK

ASSIGNED TO EXAMINER

07/05/2001

Continuous trademark protection

Get notified about every new filing that threatens MARTINDALE - THE COMPLETE DRUG REFERENCE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.